GlassScriptPhysician profile
Lorenzo Azzalini
NPI 1821562505
$232,614.85
in general payments reported to CMS, 2019-2025
31 companies · $53K in 2025
The $53K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $6,836 · 2021: $43K · 2022: $58K · 2023: $53K · 2024: $18K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Honoraria: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,900 · Travel and Lodging: $8,341 · Food and Beverage: $6,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,662.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,253.50 |
| Honoraria | $19,100.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,900.00 |
| Travel and Lodging | $8,341.22 |
| Food and Beverage | $6,603.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $66,049.77 | 2021-2025 | Impella |
| Teleflex LLC | $41,268.50 | 2019-2025 | Turnpike, Guideliner, Manta |
| Ge Healthcare | $31,546.17 | 2022-2025 | |
| Cardiovascular Systems INC. | $27,751.46 | 2019-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $24,628.41 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $15,538.31 | 2020-2025 | Diamondback Coronary, Optis |
| Reflow Medical INC | $7,512.25 | 2023-2024 | |
| Boston Scientific Corporation | $6,350.88 | 2019-2025 | General - Vascular Access, General - Therapies, General - Ct_ic |
| Arrow International, INC. | $4,329.45 | 2021-2024 | Guideliner |
| Asahi Intecc USA, INC. | $2,271.79 | 2020-2021 | |
| Vascular Solutions, INC. | $1,375.00 | 2021 | |
| Heartflow, INC. | $1,160.79 | 2019-2025 | |
| Philips North America LLC | $403.59 | 2019-2021 | |
| Cardiva Medical, INC. | $320.50 | 2019-2020 | |
| Chiesi USA, INC. | $270.48 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $240.11 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $240.08 | 2019-2020 | |
| Biotronik INC. | $230.69 | 2023-2024 | Recross |
| Medtronic, INC. | $228.95 | 2022-2024 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $179.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $128.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $124.95 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $113.28 | 2022 | |
| Edwards Lifesciences Corporation | $94.47 | 2021 | |
| Cook Medical LLC | $77.16 | 2022-2023 | Advance, Tornado |
| Cordis US Corp. | $70.66 | 2024 | Mynx Venous Vcd |
| Merit Medical Systems INC | $32.89 | 2020 | |
| Angiodynamics, INC. | $28.16 | 2025 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $26.21 | 2020 | |
| Saranas, INC. | $21.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorenzo Azzalini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.